<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1384">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04365595</url>
  </required_header>
  <id_info>
    <org_study_id>2020-00745</org_study_id>
    <nct_id>NCT04365595</nct_id>
  </id_info>
  <brief_title>SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir)</brief_title>
  <official_title>Recovery in Patients With SARS-CoV-2 Associated Respiratory Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the current
      pandemic of coronavirus disease (COVID-19) that can lead to respiratory failure requiring
      oxygen therapy. Some patients develop acute respiratory distress syndrome (ARDS) and may die
      despite intensive care therapy. Currently it is unknown a) how fast patients recover after
      being discharged from hospital and b) what underlying predictors may influence recovery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study aims:

        -  To evaluate subjective and objective recovery after discharge from hospital in patients
           with respiratory failure due to COVID-19.

        -  To identify risk factors for COVID-19 associated respiratory failure and prolonged
           recovery
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 3, 2020</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Health-related quality-of-life</measure>
    <time_frame>3 months</time_frame>
    <description>European Quality of Life - 5 Dimensions - 5 Levels Instrument (EQ-5D-5L). Scoring: Index ranges from 1 to &lt;0, with lower scores indicating more limitations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>3 months</time_frame>
    <description>Hospital Axiety and Depression Score (HADS). Scoring: Scores range from 0 to 42, with higher scores indicating more anxiety or depression symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Symptom burden</measure>
    <time_frame>3 months</time_frame>
    <description>COPD Assessment Test (CAT). Scoring: Scores range from 0-40, with higher scores indicating more symptoms due to respiratory limitations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry</measure>
    <time_frame>1 month</time_frame>
    <description>Forced expiratory volume in one second (FEV1) in liters and percent predicted.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometry</measure>
    <time_frame>1 month</time_frame>
    <description>Forced vital capacity (FVC) in liters and percent predicted.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>SARS-CoV 2</condition>
  <condition>COVID</condition>
  <arm_group>
    <arm_group_label>SARS-CoV-2 associated respiratory failure</arm_group_label>
    <description>Participants will receive a daily HrQoL questionnaire on their personal smartphone using the docdok health application during 3 months. A selection of participants will furthermore receive a custom-built home disease monitoring device during 1 month. Both procedures start at least 4 weeks after hospital discharge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaires, spirometry</intervention_name>
    <description>Questionnaires targeting health-related quality-of-life, symptoms, anxiety and depression</description>
    <arm_group_label>SARS-CoV-2 associated respiratory failure</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with SARS-CoV-2 associated respiratory failure
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  hospitalization at University Hospital Zurich due to COVID-19 infection

          -  hospital discharge max. 4 weeks ago

          -  requiring supplemental oxygen

        Exclusion Criteria:

          -  &lt;18 years

          -  non-German speaking

          -  no smartphone access
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian F Clarenbach, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Zurich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian F Clarenbach, MD</last_name>
    <phone>+41 44 255 17 12</phone>
    <email>christian.clarenbach@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian F Clarenbach, MD</last_name>
      <phone>+41 44 255 17 12</phone>
      <email>christian.clarenbach@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Dario Kohlbrenner, MSc</last_name>
      <phone>+41 43 253 08 42</phone>
      <email>dario.kohlbrenner@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 24, 2020</study_first_submitted>
  <study_first_submitted_qc>April 24, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>on reasonable request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

